Old Web
English
Sign In
Acemap
>
authorDetail
>
Maxime Galienne
Maxime Galienne
second line
Internal medicine
drug approval
Oncology
Endometrial cancer
1
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
[New drug approval: Dostarlimab - second line in advanced MSI endometrial cancer].
2021
Bulletin Du Cancer
Maxime Galienne
Manuel Rodrigues
Show All
Source
Cite
Save
Citations (2)
1